Prevalence and clinical outcomes of nontuberculous mycobacteria in a Brazilian cystic fibrosis reference center

Pathogens and Disease
Talita B AielloRenan M Mauch

Abstract

Nontuberculous mycobacteria (NTM) have been well established as an opportunistic pathogenic bacterial group for cystic fibrosis (CF) patients, with a prevalence ranging from 3% to 23% worldwide. A myriad of factors can bias the prevalence rate in different CF centers, especially misdiagnosis as systematic screening for NTM are still lacking in a number of centers. Here, we evaluated the presence and clinical outcomes of NTM isolation in microbiological respiratory cultures from CF patients attending a Brazilian reference center after setting up a systematic diagnostic protocol. Of 117 patients with respiratory samples cultured for NTM research, we found seven patients (6%) with at least one positive result for NTM [four males (57.1%), median age = 21 years (9-58)]. These cases are reported one-by-one. Median FEV1 was 40%, all patients showed signs of lung deterioration, with a median number of pulmonary exacerbations of three per patient/year. However, the impact of NTM isolation remains unclear in our center as all patients were coinfected with other CF respiratory pathogens. Our NTM prevalence assimilates to the lowest levels reported in literature, which is possibly influenced by the routinely applied Bacille Calmette-Guérin...Continue Reading

References

Apr 1, 1980·The Journal of Pediatrics·B Boxerbaum
Aug 1, 1995·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·V RomanusI Juhlin
Oct 30, 2001·Journal of Clinical Microbiology·D Yeboah-ManuS M Wilson
Nov 16, 2002·American Journal of Respiratory and Critical Care Medicine·Kenneth N OlivierUNKNOWN Nontuberculous Mycobacteria in Cystic Fibrosis Study Group
Nov 16, 2002·American Journal of Respiratory and Critical Care Medicine·Kenneth N OlivierUNKNOWN Nontuberculous Mycobacteria in Cystic Fibrosis Study Group
Apr 13, 2005·Journal of Microbiological Methods·Patricia C A M Buijtels, Pieter L C Petit
Feb 6, 2007·American Journal of Respiratory and Critical Care Medicine·David E GriffithUNKNOWN Infectious Disease Society of America
Dec 6, 2007·Revista de saúde pública·Susan M PereiraMauricio L Barreto
Oct 16, 2009·Pediatric Pulmonology·Dhenuka K RadhakrishnanSharon D Dell
Oct 23, 2009·Journal of Clinical Microbiology·Anne-Laure RouxUNKNOWN Jean-Louis Herrmann for the OMA Group
Nov 17, 2010·Environmental Health : a Global Access Science Source·William J FiskMark J Mendell
Aug 2, 2011·The Journal of Clinical Investigation·Maurizio RennaR Andres Floto
Sep 15, 2011·Journal of Bacteriology·Leonardo H F GomesLeila Mendonça-Lima
Jul 10, 2012·American Journal of Respiratory and Critical Care Medicine·Jennifer AdjemianD Rebecca Prevots
Aug 4, 2012·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Emilie CatherinotUNKNOWN OMA group
Aug 10, 2013·American Journal of Respiratory and Critical Care Medicine·Alison M BinderD Rebecca Prevots
Sep 21, 2013·Current Opinion in Pulmonary Medicine·Janice M Leung, Kenneth N Olivier
Nov 21, 2013·Annals of the American Thoracic Society·Stacey L MartinianoScott D Sagel
Apr 15, 2014·Respiratory Research·Tavs QvistTerese L Katzenstein
Jun 12, 2014·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Ophir Bar-OnHannah Blau
Jun 13, 2014·Journal of Clinical Microbiology·Pedro Henrique Campanini CândidoRafael Silva Duarte
Jul 30, 2014·American Journal of Respiratory and Critical Care Medicine·Jennifer AdjemianD Rebecca Prevots
Sep 3, 2014·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Tavs QvistUNKNOWN Scandinavian Cystic Fibrosis Study Consortium (SCFSC)
Oct 21, 2015·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Tavs QvistTania Pressler
Oct 24, 2015·The European Respiratory Journal·Tavs QvistThomas Bjarnsholt
Feb 10, 2016·Clinics in Chest Medicine·Stacey L MartinianoCharles L Daley
Mar 16, 2016·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Jason E StoutWing Wai Yew
Apr 7, 2016·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Laura VivianiR Andres Floto
Sep 2, 2016·Current Opinion in Pulmonary Medicine·Jerry A NickStacey L Martiniano
Dec 31, 2016·Current Treatment Options in Infectious Diseases·Kate SkolnikBradley S Quon
Jan 31, 2017·Pediatric Pulmonology·Jennifer M BousoOkan Elidemir
Feb 17, 2017·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Zoé CavalliIsabelle Durieu
May 14, 2017·BMC Infectious Diseases·Lander BoschLuiz Vicente Ribeiro Ferreira da Silva Filho
Apr 11, 2018·The Journal of Infectious Diseases·Petra ZimmermannNigel Curtis

❮ Previous
Next ❯

Citations

Mar 9, 2021·Pediatrics International : Official Journal of the Japan Pediatric Society·Dilber Ademhan TuralNural Kiper

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
Charles R EstherPeadar G Noone
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
Ophir Bar-OnHannah Blau
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
Tavs QvistScandinavian Cystic Fibrosis Study Consortium (SCFSC)
© 2022 Meta ULC. All rights reserved